AssetMark’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$357 Buy
10
+4
+67% +$141 ﹤0.01% 3497
2026
Q2
$188 Sell
6
-9
-60% -$380 ﹤0.01% 3429
2026
Q1
$830 Buy
15
+9
+150% +$428 ﹤0.01% 3076
2025
Q4
$224 Buy
+6
New +$244 ﹤0.01% 3239
2018
Q1
– Sell
-7
Closed – – 1826
2017
Q4
$0 Buy
+7
New +$249 ﹤0.01% 2058
2017
Q1
– Sell
-10
Closed – – 1389
2016
Q4
$0 Buy
+10
New +$273 ﹤0.01% 1347

Other funds holding PAHC

AssetMark's PAHC Position: Q3 2026 in Review

AssetMark increased its Phibro Animal Health (PAHC) stake by 67% in Q3 2026, buying an estimated $141 and bringing the position to 10 shares worth $357. The position accounts for ﹤0.01% of the portfolio, ranked #3497.

AssetMark first reported a position in PAHC in Q4 2016 and has held it in 6 quarters since. The position peaked at $830 in Q1 2026. 181 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

  • AssetMark held 10 shares of Phibro Animal Health worth $357 as of Q3 2026.
  • AssetMark bought 4 Phibro Animal Health shares in Q3 2026, an estimated $141.
  • Phibro Animal Health made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3497 holding.
  • AssetMark first reported a position in Phibro Animal Health in Q4 2016 and has held it in 6 quarters since.
  • AssetMark's Phibro Animal Health position peaked at $830 in Q1 2026.
  • 181 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.